HK1003137A1 - New pyrazine derivatives, their preparation and their use - Google Patents

New pyrazine derivatives, their preparation and their use Download PDF

Info

Publication number
HK1003137A1
HK1003137A1 HK98102228A HK98102228A HK1003137A1 HK 1003137 A1 HK1003137 A1 HK 1003137A1 HK 98102228 A HK98102228 A HK 98102228A HK 98102228 A HK98102228 A HK 98102228A HK 1003137 A1 HK1003137 A1 HK 1003137A1
Authority
HK
Hong Kong
Prior art keywords
group
alkyl
solution
formula
alkoxy
Prior art date
Application number
HK98102228A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1003137B (en
Inventor
Koppe Herbert
Speck Georg
Stockhaus Klaus
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4127026A external-priority patent/DE4127026A1/de
Priority claimed from DE19914130461 external-priority patent/DE4130461A1/de
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of HK1003137A1 publication Critical patent/HK1003137A1/xx
Publication of HK1003137B publication Critical patent/HK1003137B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
HK98102228.3A 1991-08-16 1992-07-31 New pyrazine derivatives, their preparation and their use HK1003137B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE4127026A DE4127026A1 (de) 1991-08-16 1991-08-16 Neue pyrazinderivate, ihre herstellung und verwendung
DE4127026 1991-08-16
DE19914130461 DE4130461A1 (de) 1991-09-13 1991-09-13 Neue pyrazinderivate, ihre herstellung und verwendung
DE4130461 1991-09-13
PCT/EP1992/001738 WO1993004048A1 (de) 1991-08-16 1992-07-31 Neue pyrazinderivative, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
HK1003137A1 true HK1003137A1 (en) 1998-10-09
HK1003137B HK1003137B (en) 1998-10-09

Family

ID=

Also Published As

Publication number Publication date
NO940523D0 (no) 1994-02-15
CA2115755A1 (en) 1993-03-04
HU9400430D0 (en) 1994-05-30
CZ33794A3 (en) 1994-07-13
GR3025742T3 (en) 1998-03-31
DE59208974D1 (de) 1997-11-20
AU2387092A (en) 1993-03-16
TW213903B (cs) 1993-10-01
RU94015265A (ru) 1997-02-20
ES2108129T3 (es) 1997-12-16
FI940696L (fi) 1994-02-15
RU2124008C1 (ru) 1998-12-27
NO940523L (no) 1994-02-15
JPH06509798A (ja) 1994-11-02
IE922592A1 (en) 1993-02-24
IL102814A0 (en) 1993-01-31
WO1993004048A1 (de) 1993-03-04
NZ243959A (en) 1995-07-26
EP0598770B1 (de) 1997-10-15
FI940696A0 (fi) 1994-02-15
SK17594A3 (en) 1994-12-07
HUT67661A (en) 1995-04-28
ATE159250T1 (de) 1997-11-15
FI940696A7 (fi) 1994-02-15
NO301542B1 (no) 1997-11-10
AU669122B2 (en) 1996-05-30
CZ280760B6 (cs) 1996-04-17
DK0598770T3 (da) 1997-12-15
SG46307A1 (en) 1998-02-20
EP0598770A1 (de) 1994-06-01
MX9204637A (es) 1993-02-01

Similar Documents

Publication Publication Date Title
EP0233461B2 (en) 4,5,6-Substituted-2-pyrimidinamines
US6596749B2 (en) Aminotriazole compounds
JP6182508B2 (ja) ベンゼンまたはチオフェン誘導体およびvap−1阻害剤としてのその使用
US8039493B2 (en) Biaryl sulfonamide derivatives
EP2650287B9 (en) Thiazole Derivative and use thereof as VAP-1 Inhibitor
EP0277794B1 (en) N-heterocyclic-N-(4-piperidyl) amides
HU184966B (en) Process for producing phenyl-piperazine derivatives of anti-agression activity
EP0598770B1 (de) Neue pyrazinderivative, ihre herstellung und verwendung
EP1720848B1 (fr) Derives de alkylpiperazine- et alkylhomopiperazine- carboxylates, leur preparation et leur application en tant qu'inhibiteurs de l'enzyme faah
HU196990B (en) Process for producing piperazine derivatives with antiarrhythmic effect and pharmaceuticals comprising same
JPH032144A (ja) 新規なジアミン化合物及びこれを含有する脳機能障害改善剤
JP3218243B2 (ja) ベンズイミダゾール、その製造および使用法
JP2767321B2 (ja) ピペラジン誘導体及びこれを含有する医薬
JP2003509417A (ja) トリプターゼインヒビター
AU598636B2 (en) Dihydropyridazinone derivatives, a process for their preparation and pharmaceutical preparations containing these compounds
HK1003137B (en) New pyrazine derivatives, their preparation and their use
HU220613B1 (hu) Nikotinsav-észterek, eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények és új eljárás a nikotinsav-észterek intermedierjeinek előállítására
EP1966167B1 (fr) Derives diaryltriazolmethylamine, leur preparation et leur application en therapeutique.
US4562184A (en) Substituted-aminohydroxypropoxy-thiadiazoles, β-blocking compositions and use
JP3096065B2 (ja) 医薬的に活性な鏡像体
JPH0480911B2 (cs)
JPS61115074A (ja) 3,4‐ジアゾール誘導体、その製法、およびその化合物を含有する医薬品
JPH10298197A (ja) 置換ベンズアミド誘導体
JPS6391366A (ja) 1,4−ジヒドロピリジン誘導体
JPH05148227A (ja) 抗腫瘍活性を有するヘテロ環式オリゴペプチド

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)